Database Proof Substratum: Proof LGBTQs Are Mentally Ill: Tarloxitinib Puts Tumor-Seeking Tail on Anti-EGFR Drug to Precisely Target Lung Cancer

Gendrome Editors' Note: The article below provides the raw material for a proof and is not the proof itself. In addition, the raw material may contain one or more false statements and/or some offensive, outside content.

University of Colorado Cancer Center study being presented October 28 at the AACR-NCI-EORTC International Conference on Molecular Targets: By pairing an anti-EGFR drug with a "tail" that only activates the drug when it is very near tumor cells, tarloxitinib brings the drug to tumors while keeping concentrations safe in surrounding tissues.